The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 2 study of liposomal irinotecan with 5-fluorouracil and leucovorin in squamous cell carcinoma of head and neck or esophagus after prior platinum-based chemotherapy or chemoradiotherapy.
 
Li-Yuan Bai
Honoraria - Lilly; Pfizer; SynCoreBio
Consulting or Advisory Role - Bristol-Myers Squibb
 
Muh-Hwa Yang
No Relationships to Disclose
 
Nai-Jung Chiang
No Relationships to Disclose
 
Shang-Yin Wu
Honoraria - Boehringer Ingelheim; Merck KGaA; Merck Sharp & Dohme; Novartis; Sanofi
Travel, Accommodations, Expenses - Bristol-Myers Squibb; TTY Biopharm
(OPTIONAL) Uncompensated Relationships - Novartis
 
Chen-Yuan Lin
No Relationships to Disclose
 
Ming-Yu Lien
No Relationships to Disclose
 
Jia-Hong Chen
No Relationships to Disclose
 
Mu-Hsin Chang
No Relationships to Disclose
 
Ching-Yun Hsieh
No Relationships to Disclose
 
Ruey-Long Hong
No Relationships to Disclose
 
Hsiang-fong Kao
Honoraria - Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Ono Pharmaceutical; Roche
Consulting or Advisory Role - Novartis
Speakers' Bureau - Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Ono Pharmaceutical; Roche
Research Funding - Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Novartis; Ono Pharmaceutical
 
Ren-Hua Ye
No Relationships to Disclose
 
Shang-Hung Chen
No Relationships to Disclose
 
Chin-Fu Hsiao
No Relationships to Disclose
 
Li-Tzong Chen
Leadership - ScinoPharm
Honoraria - OBI Pharma; PharmaEngine; Taivex Therapeutics
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; CStone Pharmaceuticals; Ipsen; Lilly; MSD; Novartis; Ono Pharmaceutical; SynCoreBio; TTY Biopharm
Research Funding - ACT Genomics; Bristol-Myers Squibb; Merck Serono; Novartis; Pfizer; Polaris; SynCoreBio; TTY Biopharm
Patents, Royalties, Other Intellectual Property - Anti-alpha enolase (ENO-1)monoclonal antibody / HuniLife
 
Tsang-Wu Liu
No Relationships to Disclose